Literature DB >> 23711298

Epidemiology and distribution of interstitial lung diseases in Turkey.

Benan Musellim1, Gulfer Okumus, Esra Uzaslan, Metin Akgün, Erdogan Cetinkaya, Onur Turan, Atila Akkoclu, Armagan Hazar, Nurdan Kokturk, Haluk Celalettin Calisir.   

Abstract

INTRODUCTION: There is very few data on the epidemiological features of interstitial lung diseases (ILD) in the literature. These studies on this subject suffer from limited number of patients.
OBJECTIVE: The goal of this study was to evaluate the epidemiological features of ILD in Turkey.
METHODS: Fifty-four investigators, 31 centres in 19 cities from six regions of Turkey, participated in the study. Two thousand two hundred forty-five newly diagnosed patients (51.8% females), led by Turkish Thoracic Society Clinical Problems Study Group, enrolled in this prospective study.
RESULTS: The mean age was 51.8 ± 16.7 years. The mean age among males was 50.5 ± 18.6 years and 53.0 ± 14.6 years among females (P < 0.001). 23.8% of the cases had ILD with known causes, while 39.4% were in granulomatous group, 23.7% were idiopathic, and 4.4% were in the unclassified group. Overall, histopathologically confirmed diagnosis rate was 40.4%. Sarcoidosis was the most common disease (37%), whereas cases with idiopathic pulmonary fibrosis (IPF) constituted 19,9% of patients. 53% of the sarcoidosis patients were females, and the ratio reaches to 75% under 50 years of age (for this group, IPF ratio is %3). In contrast, sarcoidosis and IPF ratios were equal in males (25%). Sarcoidosis was 8% in men over 50, while IPF was %45.
CONCLUSION: The overall incidence of ILD in Turkey was computed to be 25.8/100,000.
© 2013 John Wiley & Sons Ltd.

Entities:  

Keywords:  distribution; epidemiology; incidence; interstitial lung diseases

Mesh:

Year:  2013        PMID: 23711298     DOI: 10.1111/crj.12035

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  19 in total

1.  Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris.

Authors:  Boris Duchemann; Isabella Annesi-Maesano; Camille Jacobe de Naurois; Shreosi Sanyal; Pierre-Yves Brillet; Michel Brauner; Marianne Kambouchner; Sophie Huynh; Jean Marc Naccache; Raphael Borie; Jacques Piquet; Arsène Mekinian; Jerôme Virally; Yurdagul Uzunhan; Jacques Cadranel; Bruno Crestani; Olivier Fain; Francois Lhote; Robin Dhote; Nathalie Saidenberg-Kermanac'h; Paul-André Rosental; Dominique Valeyre; Hilario Nunes
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

2.  Survey of Physician's Knowledge, Attitudes, and Practices Regarding Idiopathic Pulmonary Fibrosis in Turkey.

Authors:  Haluk Türktaş; Gülfer Okumuş; Oğuz Uzun; Özlem Özdemir Kumbasar; Göksel Altınışık; Züleyha Bingöl; Şermin Börekçi; Vincent Cottin; Benan Müsellim
Journal:  Turk Thorac J       Date:  2020-01-01

Review 3.  [Interstitial lung diseases. The pattern is important].

Authors:  L Fink
Journal:  Pathologe       Date:  2014-11       Impact factor: 1.011

4.  Evaluation of choroidal thickness, retinal vascular caliber, and nerve fiber layer thickness in idiopathic interstitial pneumonia.

Authors:  Erhan Ugurlu; Gokhan Pekel; Betul Cengiz; Kerem Bozkurt; Goksel Altinisik
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

5.  Analysis of Age Distribution and Disease Presentation of 1269 Patients with Sarcoidosis.

Authors:  Nagihan Durmus Kocak; Sinem Gungor; Ulku Aka Akturk; Murat Yalcinsoy; Murat Kavas; Selahattin Oztas; Mevhibe Esen Akkaya; Emine Aksoy; Meltem Coban Agca; Dildar Duman; Zuhal Karakurt
Journal:  Eurasian J Med       Date:  2017-10

6.  National Registry of Interstitial Lung Disease from Pakistan.

Authors:  Ali Bin Sarwar Zubairi; Mosavir Ansarie; Talha Mahmud; Saadia Ashraf; Nisar Ahmed Rao; Arshad Javaid; Zubair Shaheen; Shereen Khan; Afzaalullah Khan
Journal:  Cureus       Date:  2021-04-25

7.  Translation, cross-cultural adaptation, and measurement properties of the Brazilian-Portuguese version of the idiopathic pulmonary fibrosis-specific version of the Saint George's Respiratory Questionnaire (SGRQ-I) for patients with interstitial lung disease.

Authors:  Wagner Florentin Aguiar; Leandro Cruz Mantoani; Humberto Silva; Camile Ludovico Zamboti; Thatielle Garcia; Vinicius Cavalheri; Marcos Ribeiro; Janelle Yorke; Fabio Pitta; Carlos Augusto Camillo
Journal:  Braz J Phys Ther       Date:  2021-07-21       Impact factor: 3.377

Review 8.  Epidemiology of idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Harold R Collard
Journal:  Clin Epidemiol       Date:  2013-11-25       Impact factor: 4.790

9.  Exploring Clinical and Epidemiological Characteristics of Interstitial Lung Diseases: Rationale, Aims, and Design of a Nationwide Prospective Registry--The EXCITING-ILD Registry.

Authors:  Michael Kreuter; Felix J F Herth; Margarethe Wacker; Reiner Leidl; Andreas Hellmann; Michael Pfeifer; Jürgen Behr; Sabine Witt; Dagmar Kauschka; Marcus Mall; Andreas Günther; Philipp Markart
Journal:  Biomed Res Int       Date:  2015-11-10       Impact factor: 3.411

Review 10.  MicroRNAs as potential targets for progressive pulmonary fibrosis.

Authors:  Subbiah Rajasekaran; P Rajaguru; P S Sudhakar Gandhi
Journal:  Front Pharmacol       Date:  2015-11-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.